SubscribeLogin
Published

Health Canada approves Moderna's mRNA RSV vaccine, company says

  • Health Canada has approved Moderna's mRNA vaccine to protect adults age 60 and older against respiratory syncytial virus .
  • Moderna's RSV vaccine, named mRESVIA, is expected to be available in early 2025.
  • The National Advisory Committee on Immunization recommended RSV immunization for adults 75 and older, and adults 60 and older in care facilities.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 71% of the sources lean Left
71% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Health CanadaHealth Canada
VaccinesVaccines
MedicalMedical
Toronto, ONToronto, ON
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal